HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$4.35
Day range
$4.32 - $4.51
Year range
$3.81 - $5.70
Market cap
262.09M USD
Avg Volume
671.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 56.26M | 18.06% |
Operating expense | 84.59M | 50.78% |
Net income | -22.59M | -324.23% |
Net profit margin | -40.15 | -259.44% |
Earnings per share | — | — |
EBITDA | -29.23M | -223.60% |
Effective tax rate | 20.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 293.75M | -21.93% |
Total assets | 601.14M | -6.82% |
Total liabilities | 135.14M | 30.08% |
Total equity | 466.00M | — |
Shares outstanding | 59.10M | — |
Price to book | 0.55 | — |
Return on assets | -12.76% | — |
Return on capital | -16.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -22.59M | -324.23% |
Cash from operations | -31.63M | -116.90% |
Cash from investing | 21.36M | 77.18% |
Cash from financing | -517.00K | — |
Net change in cash | -10.96M | -346.29% |
Free cash flow | -23.55M | -106.20% |
About
Founded
2002
Headquarters
Website
Employees
368
